Pelthos Therapeutics Inc (AMEX:PTHS) Stock News, Headlines & Updates
Pelthos Therapeutics Inc Stock News from GuruFocus
- 1
Jul 21, 2025
Pelthos Therapeutics (PTHS) Sees Price Target Boost Post-Merger | PTHS Stock News
GuruFocus News • 6:45am
Jul 10, 2025
Pelthos Therapeutics Launches ZELSUVMIâ„¢ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum
Marketwired • 7:00am
Jul 02, 2025
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement | CHRO Stock News
GuruFocus News • 6:18am
Jun 27, 2025
Channel Therapeutics (CHRO) Plans 10-for-1 Reverse Stock Split
GuruFocus News • 8:59am
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement | CHRO Stock News
GuruFocus News • 8:30am
Jun 23, 2025
CHRO: Promising Results from OpRegen Cell Therapy Study | CHRO Stock News
GuruFocus News • 12:40pm
CHRO Advances with Promising Early Trials of Hemophilia A Treatment | CHRO Stock News
GuruFocus News • 12:31pm
Jun 20, 2025
CHRO: Promising Developments in Large B-Cell Lymphoma Treatment | CHRO Stock News
GuruFocus News • 11:15am
Jun 18, 2025
MAIA Enters Agreement with Roche for Cancer Treatment Research | CHRO Stock News
GuruFocus News • 8:46am
Jun 16, 2025
CHRO Advances Prasinezumab Development for Early-Stage Parkinson's Disease | CHRO Stock News
GuruFocus News • 5:00am
Jun 04, 2025
CHRO Expands Treatment Options with New Evrysdi Tablet Approval | CHRO Stock News
GuruFocus News • 6:01am
Jun 01, 2025
CHRO: Genentech's Positive Phase III Study Results Boost Its Oncology Portfolio | CHRO Stock News
GuruFocus News • 3:15pm
May 30, 2025
CHRO Reports Promising Results for Fenebrutinib in Multiple Sclerosis | CHRO Stock News
GuruFocus News • 5:49am
May 27, 2025
CHRO Advances Potential Superbug Antibiotic to Late-Stage Trials | CHRO Stock News
GuruFocus News • 8:45am
May 23, 2025
Promising Results for CHRO in Two-Year Study on Columvi Therapy for Lymphoma | CHRO Stock News
GuruFocus News • 4:47am
May 22, 2025
FDA Approves Susvimo for Diabetic Retinopathy Treatment | CHRO Stock News
GuruFocus News • 11:15am
May 20, 2025
CHRO Announces FDA Advisory Committee Review for Cancer Treatment | CHRO Stock News
GuruFocus News • 2:15pm
May 14, 2025
Roche Investment Plans in the U.S. Under Threat Due to Executive Order | CHRO Stock News
GuruFocus News • 1:16pm
Channel Therapeutics (CHRO) Reaches Key Milestones in Ocular Pain Studies | CHRO Stock News
GuruFocus News • 7:47am
May 13, 2025
CHRO Announces Promising Results from Phase III Breast Cancer Study | CHRO Stock News
GuruFocus News • 5:04am
May 12, 2025
Roche Plans Major Investment in Indianapolis Site, Enhancing CGM Production | CHRO Stock News
GuruFocus News • 9:47am
May 01, 2025
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules | CHRO Stock News
GuruFocus News • 4:19pm
Apr 29, 2025
FDA Grants Breakthrough Status to Roche's VENTANA TROP2 RxDx Device | CHRO Stock News
GuruFocus News • 5:46am
Apr 28, 2025
HSBC Downgrades Roche Amidst Concerns of Overpopulation in the Trade | CHRO Stock News
GuruFocus News • 4:16am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news